2019, Number 4
<< Back
Rev Med Inst Mex Seguro Soc 2019; 57 (4)
Pituitary apoplexy secondary to pituitary macroadenoma, a diagnostic challenge
Sánchez-Tinajero Á, Ruiz-Santillán DP
Language: Spanish
References: 25
Page: 259-263
PDF size: 264.01 Kb.
ABSTRACT
Background: Pituitary apoplexy is a clinical syndrome
reflecting a rapid expansion of sellar content, typically
secondary to a stroke in a previous pituitary adenoma. This
pathology is a rare complication, and, therefore,
underdiagnosed. The consequences of a delay in the
diagnosis are translated into serious functional and even
deadly complications for the patient.
Case report: We present the case of a 42-year-old male
patient, who began his condition with a diffuse clinical setting,
characterized by headache, amblyopia, and alterations of
consciousness. The diagnosis was pituitary apoplexy, and
secondary hypopituitarism, and it was treated in a
conservative way, with steroid anti-inflammatories and
hormonal substitution. The patient presented a psychotic
episode induced by steroids, due to the supraphysiological
doses used, necessary to reverse the existing neurological
damage; however, it ended in a
restitutio ad integrum 15 days
after medical treatment, without requiring neuro-surgical
intervention.
Conclusions: The clinical case presented and its resolution
are clear evidence of the importance of a timely and adequate
diagnosis, given that being detected in early stages, and
treated early according to the evolution of the pathology, will
not always require surgical intervention, allowing a total
neurological restitution.
REFERENCES
Ricciuti R, Nocchi N, Arnaldi G, Polonara G, Luzi M. Pituitary Adenoma Apoplexy: Review of Personal Series. Asian J Neurosurg. 2018;13(3):560-564. DOI: 10.4103/ajns.AJNS_344_16.
Fernández Y, Villaseñor E, Sánchez O, Martínez M, Roldán E. Apoplejía pituitaria: Evaluación convencional con resonancia magnética. Med Sur. 2009;16(2):74-8.
Català M, Picó A, Tortosa F, Varela C, Gilsanz A, Lucas T, et al. Guía clínica del diagnóstico y tratamiento de la apoplejía hipofisaria. Rev Endocrinol Nutr. 2006;53(1):19-24.
Wildemberg L, Glezer A, Bronstein M, Gadelha M. Apoplexy in nonfunctioning pituitary adenomas. Pituitary. 2018;21(2):138-44. DOI: 10.1007/s11102-018-0870-x.
Shatri J, Ahmetgjekaj I. Rathke's Cleft Cyst or Pituitary Apoplexy: A Case Report and Literature Review. Maced J Med Sci. 2018;6(3):544-7. DOI: 10.3889/oamjms.2018.115
Comuñas F, Al-Ghanem R, Calatayud V. Apoplejía hipofisaria. Neurocirugía. 2003;14(6):483-538. DOI: 10.1016/S1130-1473 (03)70508-9
Komshiam S, Saket R, Bakhadirov K. Pituitary Apoplexy With Bilateral Oculomotor Nerve Palsy. Neurohospitalist. 2018;8(3):4-5. DOI: 10.1177/1941874418773923
Abbara A, Clarke S, Ing P, Milburn J, Joshi D, Comninos A, et al. Clinical and biochemical characteristics of patients presenting with pituitary apoplexy. Endocr Connect. 2018;7 (10):1058-66. DOI: 10.1530/EC-18-0255.
Briet C, Salenave S, Bonneville J, Laws E, Chanson P. Pituitary Apoplexy. Endocr Rev. 2015;36(6):622-45. DOI: 10.1210/er.2015-1042
Seo Y, Kim Y, Dho Y, Kim J, Kim J, Park C, et al. The outcomes of pituitary apoplexy with conservative treatment: experiences at a single institution. World Neurosurg. 2018;115:e703-10. DOI: 10.1016/j.wneu.2018.04.139.
Zoli M, Guaraldi F, Faustini M, Mazzatenta D. Myasthenia gravis imitating pituitary apoplexy in macroprolactinoma. Hormones. 2018;17(3):423-6. DOI: 10.1007/s42000-018- 0036-2.
Cossuo G, Dimitriou J, Brouland J, Daniel R, Messerer M. An exceptional presentation of pituicytoma apoplexy: A case report. Oncol Lett. 2018;6(1):643-7. DOI: 10.3892/ol.2018. 8625.
Billeci D, Marton E, Giordan E. Post-traumatic pituitary apoplexy: Case presentation and review of literature. Interdisciplinary Neurosurgery. 2017;7:4-8. DOI: 10.1016/j.inat. 2016.10.006
Goyal P, Utz M, Gupta N, Kumar Y, Mangla M, Gupta S, et al. Clinical and imaging features of pituitary apoplexy and role of imaging in differentiation of clinical mimics. Quant Imaging Med Surg. 2018;8(2):219-31. DOI: 10.21037/qims.2018.03. 08
Ranabir S, Baruah M. Pituitary apoplexy. Indian J Endocrinol Metab. 2011;15(3):188-96. DOI: 10.4103/2230- 8210.84862.
Douleh D, Morone P, Mobley B, Fusco M, Chambless L. Angioplasty is an Effective Treatment for Vasospasm Following Pituitary Apoplexy and Tumor Resection. Cureus. 2018;10(1):e2117. DOI: 10.7759/cureus.2117
Lammert A, Walter MS, Giordano FA, Al Zhgloul M, Krämer BK, Nittka S, et al. Neuro-Endocrine Recovery After Pituitary Apoplexy: Prolactin as a Predictive Factor. Exp Clin Endocrinol Diabetes, 2018. DOI: 10.1055/a-0640-2915.
Culpin E, Crank M, Igra M, Connolly D, Dimitri P, Mirza S, et al. Pituitary tumour apoplexy within prolactinomas in children: a more aggressive condition? Pituitary. 2018; 21 (5):474-9. DOI: 10.1007/s11102-018-0900-8
Vicente A, Lecumberri B, Gálvez M. Guía de práctica clínica para el diagnóstico y tratamiento de la apoplejía hipofisaria. Endocrinol Nutr. 2013;60(10):582.e1-12. DOI: 10.1016/j.endonu.2013.04.013
Gan L, Ma J, Feng F, Wang Y, Cui J, Guo X, et al. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression. World Neurosurg. 2018;116:960-7. DOI: 10.1016/j.wneu.2018.05.141.
Gupta P, Dutta P. Landscape of Molecular events in Pituitary Apoplexy. Front Endocrinol (Lausanne). 2018;9: 107. DOI: 10.3389/fendo.2018.00107
Saberifard J, Yektanezhad T, Assadi M. An Interesting Case of a Spontaneous Resolution of Pituitary Adenoma after Apoplexy. J Belg Soc Radiol. 2015;99(1):101-2. DOI: 10.5334/jbr-btr.851
Kawahigashi T, Nishiguchi S. Pituitary apoplexy with a binasal visual field defect. QJM. 2018;111(9):657-8. DOI: 10.1093/qjmed/hcy051.
Gupta K, Sahni S, Saggar K, Vashisht G. Evaluation of Clinical and Magnetic Resonance Imaging Profile of Pituitary Macroadenoma: A Prospective Study. J Nat Sci Biol Med. 2018;9(1):34-8. DOI: 10.4103/jnsbm.JNSBM_111_17
Slaehi N, Firek A, Munir I. Pituitary Apoplexy Presenting as Ophthalmoplegia and Altered Level of Consciousness without Headache. Case Rep. Endocrinol. 2018;(4):1-6. DOI: 10.1155/2018/7124364